Forced downregulation of RACK1 inhibits glioma development by suppressing Src/Akt signaling activity

Oncology Reports

Volumn 30, Issue 5, 2013, Pages 2195-2202

  Peng, Renjun ^a   Jiang, Bing ^a   Ma, Jianrong ^a   Ma, Zhiming ^a   Wan, Xin ^a   Liu, Hongwei ^a   Chen, Zigui ^a   Cheng, Quan ^a   Chen, Rui ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Glioma; Invasion; Proliferation; Receptor for activated C kinase 1

Indexed keywords

MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN TYROSINE KINASE; RECEPTOR FOR ACTIVATED C KINASE 1; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN TISSUE; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CANCER TISSUE; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME REPRESSION; GENE EXPRESSION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; TUMOR INVASION; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; GTP-BINDING PROTEINS; HUMANS; MICE; MOLECULAR TARGETED THERAPY; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CELL SURFACE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84885051395     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2723     Document Type: Article

References (30)

1. Stewart LA: Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359: 1011-1018, 2002.
2. Zhu VF, Yang J, Lebrun DG and Li M: Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis. Cancer Lett 316: 139-150, 2012.
3. Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ and Rich JN: Molecularly targeted therapy for malignant glioma. Cancer 110: 13-24, 2007.
4. Linz U: Commentary on effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Cancer 116: 1844-1846, 2010.
5. Lancet Oncol 2009;10:459-466
6. Pulkkanen KJ and Yla-Herttuala S: Gene therapy for malignant glioma: current clinical status. Mol Ther 12: 585-598, 2005.
7. Dorn GW 2nd and Mochly-Rosen D: Intracellular transport mechanisms of signal transducers. Annu Rev Physiol 64: 407-429, 2002.
8. Adams DR, Ron D and Kiely PA: RACK1, a multifaceted scaffolding protein: structure and function. Cell Commun Signal 9: 22, 2011.
9. Wan L, Xie Y, Su L, Liu Y, Wang Y and Wang Z: RACK1 affects morphine reward via BDNF. Brain Res 1416: 26-34, 2011.
10. Battaini F, Pascale A, Paoletti R and Govoni S: The role of anchoring protein RACK1 in PKC activation in the ageing rat brain. Trends Neurosci 20: 410-415, 1997.
11. Marqués N, Sesé M, Cánovas V, et al: Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1. Oncogene: Mar 04, 2013 (Epub ahead of print). doi: 10.1038/onc.2013.51.
12. Guo Y, Wang W, Wang J, et al: Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity. Hepatology 57: 140-151, 2013.
13. Cao XX, Xu JD, Xu JW, et al: RACK1 promotes breast carcinoma migration/metastasis via activation of the RhoA/Rho kinase pathway. Breast Cancer Res Treat 126: 555-563, 2011.
14. Trerotola M, Li J, Alberti S and Languino LR: Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin-RACK1 axis. J Cell Physiol 227: 3670-3677, 2012.
15. Wu J, Meng J, Du Y, et al: RACK1 promotes the proliferation, migration and invasion capacity of mouse hepatocellular carcinoma cell line in vitro probably by PI3K/Rac1 signaling pathway. Biomed Pharmacother 67: 313-319, 2013.
16. Ruan Y, Sun L, Hao Y, et al: Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma. J Clin Invest 122: 2554-2566, 2012.
17. Li G, Ji XD, Gao H, et al: EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex. Nat Commun 3: 667, 2012.
18. Lu F, Zhang C, Wu WJ and Wu YM: RACK1 downregulation suppresses migration and proliferation of neuroblastoma cell lines. Oncol Rep 27: 1646-1652, 2012.
19. Li J, Guo Y, Feng X, et al: Receptor for activated C kinase 1 (RACK1): a regulator for migration and invasion in oral squamous cell carcinoma cells. J Cancer Res Clin Oncol 138: 563-571, 2012.
20. Wang F, Osawa T, Tsuchida R, Yuasa Y and Shibuya M: Downregulation of receptor for activated C-kinase 1 (RACK1) suppresses tumor growth by inhibiting tumor cell proliferation and tumor-associated angiogenesis. Cancer Sci 102: 2007-2013, 2011.
21. van Delft MF, Wei AH, Mason KD, et al: The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 10: 389-399, 2006.
22. Gelman IH: Src-family tyrosine kinases as therapeutic targets in advanced cancer. Front Biosci 3: 801-807, 2011.
23. Aleshin A and Finn RS: SRC: a century of science brought to the clinic. Neoplasia 12: 599-607, 2010.
24. Doan AT and Huttenlocher A: RACK1 regulates Src activity and modulates paxillin dynamics during cell migration. Exp Cell Res 313: 2667-2679, 2007.
25. Huveldt D, Lewis-Tuffin LJ, Carlson BL, et al: Targeting Src family kinases inhibits bevacizumab-induced glioma cell invasion. PLoS One 8: e56505, 2013.
26. Stedt H, Alasaarela L, Samaranayake H, et al: Specific inhibition of SRC kinase impairs malignant glioma growth in vitro and in vivo. Mol Ther Nucleic Acids 1: e19, 2012.
27. Creedon H and Brunton VG: Src kinase inhibitors: promising cancer therapeutics? Crit Rev Oncog 17: 145-159, 2012.
28. Sheppard K, Kinross KM, Solomon B, Pearson RB and Phillips WA: Targeting PI3 kinase/AKT/mTOR signaling in cancer. Crit Rev Oncog 17: 69-95, 2012.
29. Hemmings BA and Restuccia DF: PI3K-PKB/Akt pathway. Cold Spring Harb Perspect Biol 4: a011189, 2012.
30. Mamidipudi V and Cartwright CA: A novel pro-apoptotic function of RACK1: suppression of Src activity in the intrinsic and Akt pathways. Oncogene 28: 4421-4433, 2009.